MAXAID
1107 NE 45TH NO 230, SEATTLE, WA 98105 www.maxaid.org

---

Organizations Filed Purposes: MAXAID IS A 501(C)(3) NON-PROFIT THAT WAS SET UP BY THE MAX FOUNDATION AS A SUBSIDIARY TO SUPPORT ITS MISSION OF INCREASING GLOBAL ACCESS TO TREATMENT, CARE, AND SUPPORT FOR PEOPLE LIVING WITH CANCER. THE PRIMARY PURPOSE OF MAXAID IS TO CARRY OUT TREATMENT ACCESS SOLUTIONS FOR ONCOLOGY PRODUCTS IN LOW-AND-MIDDLE INCOME COUNTRIES IN PARTNERSHIP WITH THE MAX FOUNDATION.

MAXAID IS A 501(C)(3) NON-PROFIT THAT WAS SET UP BY THE MAX FOUNDATION AS A SUBSIDIARY TO SUPPORT ITS MISSION OF INCREASING GLOBAL ACCESS TO TREATMENT, CARE, AND SUPPORT FOR PEOPLE LIVING WITH CANCER.

FROM ITS LAUNCH, MAXAID HAS HOSTED THE MAX FOUNDATION'S COLLABORATION WITH NOVARTIS, A LEADING GLOBAL HEALTHCARE COMPANY, AROUND HUMANITARIAN ACCESS TO THEIR MEDICINES GLIVEC AND TASIGNA IN A JOINT INITIATIVE KNOWN AS CMLPATH TO CARE. IN 2019, THE COLLABORATION ENABLED THOUSANDS OF PATIENTS IN LOW- AND MIDDLE-INCOME COUNTRIES TO ACCESS MUCH NEEDED ONCOLOGY PRODUCTS THAT THEY WOULD NOT HAVE OTHERWISE BEEN ABLE TO ACCESS. ACCESS TO MEDICINES WAS ENABLED THROUGH THE MAX FOUNDATION'S PATIENT-CENTERED TREATMENT ACCESS MODEL KNOWN AS MAX ACCESS SOLUTIONS. IN THE CASE OF MAXAID, ONCOLOGY PRODUCTS WERE RECEIVED FROM THE DRUG MANUFACTURER NOVARTIS AND CHANNELED TO INIDVIDUAL PATIENTS VIA THE MAX FOUNDATION'S NETWORK OF HEALTHCARE PROVIDERS AND TREATMENT CENTERS.

---

---

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202033039349301423_public.xml